The Administrative Core is directed by Dr. Lawrence Corey, the overall Principal Investigator of the Program Project. The goals of the Administrative Core are to 1) coordinate the administrative, fiscal and organizational aspects of the entire program project;2) facilitate scientific communication among the clinical facilities, laboratories, investigators and participants involved in these studies;3) interface with site personnel in evaluating and accessing operational and fiscal activities and developments;4) coordinate IRB submissions, renewals and updates, and human subjects training compliance;5) provide fiscal oversight of thePOL The Administrative Core also coordinates the courier services utilized to transport specimens between laboratories and clinics and will coordinate transport of specimens from the international sites. The Administrative Core oversees the arrangements for the External Advisory Board. The Advisory Board meets at 12-18 month intervals with the Project and Core leaders and investigative staff, to review the progress of the program. These administrative functions are centralized from the offices of Dr. Corey at the Fred Hutchinson Cancer Research Center. This is the central location of the combined programs in Infectious Diseases at the FHCRC and Virology Division of the University of Washington. As with other parts of the P01 these personnel are split between FHCRC and UW based persons.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI030731-22
Application #
8382103
Study Section
Special Emphasis Panel (ZAI1-MMT-M)
Project Start
Project End
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
22
Fiscal Year
2012
Total Cost
$285,594
Indirect Cost
$54,561
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Ott, Mariliis; Jing, Lichen; Lorenzo, Lazaro et al. (2017) T-cell Responses to HSV-1 in Persons Who Have Survived Childhood Herpes Simplex Encephalitis. Pediatr Infect Dis J 36:741-744
Matrajt, Laura; Gantt, Soren; Mayer, Bryan T et al. (2017) Virus and host-specific differences in oral human herpesvirus shedding kinetics among Ugandan women and children. Sci Rep 7:13105
Ramchandani, Meena; Selke, Stacy; Magaret, Amalia et al. (2017) Prospective cohort study showing persistent HSV-2 shedding in women with genital herpes 2 years after acquisition. Sex Transm Infect :
Abana, Chike O; Pilkinton, Mark A; Gaudieri, Silvana et al. (2017) Cytomegalovirus (CMV) Epitope-Specific CD4+ T Cells Are Inflated in HIV+ CMV+ Subjects. J Immunol 199:3187-3201
Celum, Connie; Hong, Ting; Cent, Anne et al. (2017) Herpes Simplex Virus Type 2 Acquisition Among HIV-1-Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study. J Infect Dis 215:907-910
Hensel, Michael T; Peng, Tao; Cheng, Anqi et al. (2017) Selective Expression of CCR10 and CXCR3 by Circulating Human Herpes Simplex Virus-Specific CD8 T Cells. J Virol 91:
Koelle, David M; Norberg, Peter; Fitzgibbon, Matthew P et al. (2017) Worldwide circulation of HSV-2?×?HSV-1 recombinant strains. Sci Rep 7:44084
Gilbert, Peter B; Excler, Jean-Louis; Tomaras, Georgia D et al. (2017) Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women. PLoS One 12:e0176428
Looker, Katharine J; Magaret, Amalia S; May, Margaret T et al. (2017) First estimates of the global and regional incidence of neonatal herpes infection. Lancet Glob Health 5:e300-e309
Traidl, Stephan; Kienlin, Petra; Begemann, Gabriele et al. (2017) Patients with atopic dermatitis and history of eczema herpeticum elicit herpes simplex virus-specific type 2 immune responses. J Allergy Clin Immunol :

Showing the most recent 10 out of 340 publications